Melbourne Paediatric Specialists

 

A/Prof Adam Scheinberg

Paediatric Rehabilitation
Paediatric Rehabilitation Medicine Specialist

A/Prof Adam Scheinberg

MBBS FRACP FAFRM DCH MMed

Paediatric Rehabilitation

Clinical Interests

A/Prof Adam Scheinberg’s clinical interests include all paediatric and young adult rehabilitation including cerebral palsy, spinal cord injury, acquired brain injury and concussion, reconditioning after illness or injury, chronic fatigue syndrome. He is accredited in administering Botulinum toxin injections and Intrathecal Baclofen infusion, and is experienced in muscle tone assessment for a range of interventions including selective dorsal rhizotomy.

Background and experience

Adam is a paediatric rehabilitation specialist, statewide medical director of the Victorian Paediatric Rehabilitation Service and Head of Department for Paediatric Rehabilitation at the Royal Children’s Hospital. He consults regularly at VPRS sites in Victoria and Tasmania.

Adam trained in Sydney at the Children’s Hospital Westmead before moving to Victoria at the start of 2009. Adam has over 15 years of experience in paediatric and young adult rehabilitation.

Research Interests

Adam is an active clinical researcher. He is an Associate Investigator on 2 NHMRC Centre’s of Excellence for Brain Injury (Sydney) and Cerebral Palsy (Melbourne). He is a chief investigator on the Mason Foundation Grant for Chronic Fatigue Syndrome. He is also involved in Spinal Cord Injury research and supervises medical students and Masters students.

Publications →

(Past 5 years only)

  • Burns F, Stewart R, Reddihough D, Scheinberg A, Ooi K, Graham HK. The cerebral palsy transition clinic: administrative chore, clinical responsibility, or opportunity for audit and clinical research? Journal of Children’s Orthopaedics: Volume 8, Issue 3 (2014), Page 203-213
  • Sarah Knight, Adrienne Harvey, Susan Towns, Donald Payne, Lionel Lubitz, Kathy Rowe, Colette Reveley, Sabine Hennel and Adam Scheinberg. How is Paediatric Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Diagnosed and Managed by Paediatricians? An Australian National Study. J Paeds Child Health 2014; doi10.1111/jpc.12677.
  • Knight, S., Harvey, A., Lubitz, L., Rowe, K., Reveley, C., Veit, F., Hennel, S. and Scheinberg, A. ‘Paediatric chronic fatigue syndrome: complex presentations and protracted time to diagnosis’, Journal of Paediatrics and Child Health 2013; vol.49(11), pp.919-24
  • Jane Galvin, Adam Scheinberg , and Peter New A Retrospective Case Series of Pediatric Spinal Cord Injury and Disease in Victoria, Australia SPINE Volume 38, Number 14, pp E878-E882
  • Knight S, Scheinberg A, Harvey A. Interventions in Pediatric Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A Systematic Review. Journal of Adolescent Health 53 (2013), pp. 154-165 DOI information: 10.1016/j.jadohealth.2013.03.009
  • Ware T, Srinivasan J, Gonzalez L, Hardikar W, Scheinberg A, Baker L, Prakash C, Ryan M. Juvenile parkinsonism – Instructive Case. J Paeds Child Health. JPC2011-0315.
  • Forrester M, Mihrshahi , Waugh M, O’Flaherty S, Rice J, Graham K, Scheinberg A. Conscious sedation or general anaesthetic for intramuscular BoNT-A injections in children – a two centre cross-sectional prospective audit. Letter to the Editor. European Journal of Paediatric Neurology 16 (2012), pp. 215-217 DOI information: 10.1016/j.ejpn.2011.07.006
  • Scheinberg AM. Commentary: Screening for children born extremely preterm and extremely low birth-weight – a role for health-related quality of life measures? Developmental Medicine & Child Neurology 2011; vol.53(10), pp.878-80
  • Morrow AM, Hayen A, Quine S, Scheinberg A, Craig JC. A comparison of doctors’, parents’ and children’s reports of health states and health-related quality of life in children with chronic conditions. Child Care Health Dev. 2011 Jun 8. doi: 10.1111/j.1365-2214.2011.01240.x. [Epub ahead of print]
  • Alhusani A, Crosbie J, Shepherd R, Dean C, Scheinberg A. No change in passive muscle stiffness following Botulinum toxin injection to the calf in children with cerebral palsy. Dev Med Child Neurol. 2011,53:553-558
  • O’Flaherty S J, Janakan V, Morrow A, F, Scheinberg A, Waugh M. Botulinum Toxin Adverse Events and Health Status in children with Cerebral Palsy in all GMFCS levels. Dev Med Child Neurol. 2011,53:125-130
  • Burns J. Scheinberg A. Ryan MM. Rose KJ. Ouvrier RA. Randomized trial of botulinum toxin to prevent pes cavus progression in pediatric CMT1A. Muscle & Nerve 2010;42(2): 262-267.
  • Snyman N, Gilles J, Egan J, Giles R, Scheinberg A. The effect of zolpidem on the level of consciousness in children with severe acquired brain injury. Neuropediatrics 2010;41:223-27
  • Alhusani A, Crosbie J, Shepherd R, Dean C, Scheinberg A. Passive mechanical properties of the calf muscles in children with cerebral palsy compared to healthy children. Dev Med Child Neurol. 2010 Jun;52(6):e101-6. Epub 2010 Jan 28.
  • Field B, Cruickshank A, Scheinberg A. Health care services for adults with Cerebral Palsy. Australian Family Physician 2010;39 (3):165-167
  • Ward A, Hayden S, Dexter M, Scheinberg A. Continuous intrathecal baclofen for children with spasticity and/or dystonia: goal attainment and complications associated with treatment. J Paeds Child Health 2009;45(12):720-726
  • Scheinberg A. Clinical Use of Botulinum toxin. Australian Prescriber 2009;32(2):39-42

Presentations →

  • xxxxx

Hospitals Accredited

  • Royal Children’s Hospital, Melbourne.
  • Ballarat Health Services
  • Bendigo Health
  • Eastern Health
  • Barwon Health